Annalists covering SSH will have to upgrade their buy rating to the extreme , the market will understand why very quickly , the FDA also will have no choice but to move quickly when no other promising treatment that works is in sight, SSH has a potential $90 billion addressable market all to itself , $100 plus per share can be closer than you think.
- Forums
- ASX - By Stock
- A gentlemanly dispute
Annalists covering SSH will have to upgrade their buy rating to...
-
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)